VEDANTA PARTNERS LLC 13D and 13G filings for Reviva Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-31 9:30 pm Sale | 2024-05-29 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | VEDANTA PARTNERS LLC | 6,251,606 18.500% | -152,811 (-2.39%) | Filing |
| 2023-11-30 4:49 pm Purchase | 2023-11-20 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | VEDANTA PARTNERS LLC | 6,404,417 19.900% | 339,243 (+5.59%) | Filing |
| 2022-09-12 4:35 pm Purchase | 2022-09-08 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | VEDANTA PARTNERS LLC | 6,065,174 19.900% | 2,766,798 (+83.88%) | Filing |
| 2021-06-03 5:16 pm Purchase | 2021-06-01 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH | VEDANTA PARTNERS LLC | 3,298,376 18.100% | 3,298,376 (New Position) | Filing |